Should the Supreme Court weaken or overturn the Chevron doctrine, federal agencies will likely rely more heavily on guidance documents to avoid judicial oversight, health policy experts say. A report from the Paragon Health Institute argues for the restoration of Trump-era good guidance practices (GGPs) to force agencies to be more transparent in their development of sub-regulatory guidance documents. Paragon’s Joel Zinberg, the paper’s author, argues guidance development should have safeguards, such as notice and public comment and centralized...